MHRA: Safety of OTC products containing codeine ‘under review’

The Medicines and Healthcare products Regulatory Agency (MHRA) is keeping the “safety and availability” of codeine-based products “under review”, it has told C+D.

MHRA.jpg
MHRA: All opioid-based painkillers could be reclassified if necessary

Latest from News

More from Regulation